RAD Announces Positive Data from RAD301 P1 Imaging Trial

Sep 8, 2026 at 7:21 PM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Sep 8, 2026 at 7:21 PM EDT

On 6ix: 6ix.com/news/rad-announces-positive-data-from-rad301-p1-imaging-trial

ASX ANNOUNCEMENT September 9, 2026 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Story so far

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical TrialAug 20, 2026
Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain MetastasesApr 16, 2026
Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain MetastasesMar 24, 2026

Earlier from Radiopharm Theranostics

Appendix 4E and Preliminary Final ReportAug 28
Change of Director's Interest Notices x 4Aug 27
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid TumorsAug 26
RAD Doses First Patient in Second Cohort of BetaBart (RV-01)Aug 25
Ceasing to be a substantial holderAug 24

Later from Radiopharm Theranostics

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal AdenocarcinomaSep 9
Results of MeetingSep 10
RAD oral presentation at SNO26 on RAD101 Phase IIb dataSep 13
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual MeetingSep 14
Share purchase plan completedSep 16

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics